Skip to main content
Caplight Logo









General Fluidics Corporation

General Fluidics Corporation

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://www.generalfluidics.com/

Last Round

Series B

Jul 16, 2024

Total Funding Raised

$34.84M

Company Overview

General Fluidics Corporation is a medical equipment and supplies manufacturing company that develops a novel, automated point-of-care diagnostic platform for clinical chemistry, hematology, and immunoassays.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care testingPOCTIVDin-vitro diagnosticsclinical diagnosticsdiagnostic platformimmunoassayhematology testingclinical chemistrymicrofluidicslab-on-a-chipdiagnostic cartridgesbenchtop analyzerurgent care diagnosticsmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

General Fluidics Corporation Comparables

Compare General Fluidics Corporation with similar companies based on industry and business-model similarity.

General Fluidics Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chengdu Seamaty Technology Co., Ltd.
84%
Soulbrain Holdings Co. Ltd
79%
Sight Diagnostics
77%

General Fluidics Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 16, 2024
DebtJun 29, 2022
Series ADec 9, 2020
SeedSep 24, 2018
GrantSep 15, 2014

Key People

Founding team and executive leadership

Keith Greenfield

Business Development Advisor to CEO

Executive Team

Robert Granier

CEO

Executive Team

Robert S. Warren

Chief Operating Officer

Executive Team

General Fluidics Corporation Investors

Notable investors and investment history

General Fluidics Corporation investors
InvestorRounds
Kendall Capital PartnersDebt, Series B
National Heart, Lung, and Blood InstituteGrant

General Fluidics Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

General Fluidics Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about General Fluidics Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range17
Year Founded2014
Last FundingJul 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?